Skip to main content
. Author manuscript; available in PMC: 2014 Apr 12.
Published in final edited form as: Chem Biol. 2009 Apr 24;16(4):432–441. doi: 10.1016/j.chembiol.2009.02.010

Table 1.

Gene Products Identified by mRNA Expression Profiling in Mice and Reverse Genetics in Zebrafish

Gene Name Gene Ontology Molecular Function mRNA Expression Profile
Functional Validation
Vascular Selectivity Pref. Vasc. Bed Pref. Stage cdh5 ISH FITC-Dextran
alox5ap Enzyme activator activity Yes Skin - 0% 48%

ctsz Cysteine-type peptidase activity Yes - - 12% 19%

fzd6 G protein-coupled receptor activity Yes - - 21% 55%

gnb2l1 GTPase activity Yes - Embryo 12% 49%

hexb β-N-acetylhexosaminidase activity Yes Brain Adult 28% 58%

kiaa1274 Protein tyrosine phosphatase activity Yes Brain Embryo 10% 53%

p2ry5 Purinergic receptor activity, G protein coupled Yes Skin Adult 20% 24%

ppap2a Phosphatidate phosphatase activity Yes - Adult 48% 57%

ppih Cyclosporin A binding Yes Heart Embryo 3% 82%

ppp1ca Protein Ser/Thr phosphatase activity Yes - Embryo 0% 81%

ppp1cc Protein Ser/Thr phosphatase activity No Brain - 32% 44%

ppp4c Protein Ser/Thr phosphatase activity Yes Heart Embryo 18% 28%

rab11a GTPase activity Yes Heart Adult 0% 32%

rab5c GTPase activity Yes Skin - 0% 54%

ralb GTP binding Yes - Embryo 12% 84%

sat1 Diamine N-acetyltransferase activity Yes Heart Embryo 0% 43%

All gene names are for human genes. Vascular selectivity was defined as “Yes” or “No,” where “Yes” corresponded to upregulated (p < 0.05) signal in one or more comparisons of vascular fragments against nonvascular tissues, and “No” corresponded to nonregulated signal in one or more comparisons of vascular fragments against nonvascular tissues. Preferentially enriched expression in a vascular bed (Pref. Vasc. Bed) was defined as upregulated (p < 0.05) signal in one vascular bed compared to another vascular bed. Significantly higher expression of a gene at embryonic or adult stages was indicated as either preferred “Embryo” or “Adult.” The underlying data are presented in Table S2. cdh5 ISH, the percentage of zebrafish embryos with aberrant cdh5 expression in the intersegmental vessels at 48–56 hpf, as detected by in situ hybridization. FITC-Dextran, the percentage of zebrafish embryos with defective intersegmental vessels evident by FITC-dextran microangiography at 48–56 hpf. Details of reduced cdh5 staining and/or FITC-dextran labeling are shown in Figure S4.